Michael E. B. Spicer
Directeur Financier/CFO chez Orchid GeneScreen, Inc.
Profil
Michael E.
B.
Spicer is currently the Chief Financial Officer & Vice President at Orchid GeneScreen, Inc. Prior to this, he was the Chief Financial Officer at NovaDel Pharma, Inc. from 2004 to 2009, the Chief Financial Officer at Orchid Cellmark, Inc. from 2001 to 2004, and the Chief Financial Officer & Vice President at Lifecodes Corp.
from 1998 to 2001.
He received his undergraduate degree from the University of Virginia and his MBA from Harvard University.
Postes actifs de Michael E. B. Spicer
| Sociétés | Poste | Début |
|---|---|---|
Orchid GeneScreen, Inc.
 Orchid GeneScreen, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid GeneScreen, Inc. provides DNA testing services for the human and animal identity markets. The firm offers genetics and identity testing for paternity, and forensics. It provides services to private, government and other agencies. The company was founded in 1987 and is headquartered in Dallas, TX. | Directeur Financier/CFO | - |
Anciens postes connus de Michael E. B. Spicer
| Sociétés | Poste | Fin |
|---|---|---|
| NOVADEL PHARMA INC | Directeur Financier/CFO | 01/04/2009 |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Directeur Financier/CFO | 01/12/2004 |
Lifecodes Corp.
 Lifecodes Corp. Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Lifecodes Corp. is a company that provides paternity testing services. The company is based in Stamford, CT. Lifecodes was acquired by Orchid Cellmark, Inc., part of Laboratory Corp. of America Holdings from December 15, 2011 on December 06, 2001 for $26.53 million. The company was founded by Ronald C. Dorazio. | Directeur Financier/CFO | 01/12/2001 |
Formation de Michael E. B. Spicer
| University of Virginia | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NovaDel Pharma, Inc.
 NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ. | Health Technology |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
Orchid GeneScreen, Inc.
Orchid GeneScreen, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid GeneScreen, Inc. provides DNA testing services for the human and animal identity markets. The firm offers genetics and identity testing for paternity, and forensics. It provides services to private, government and other agencies. The company was founded in 1987 and is headquartered in Dallas, TX. | Commercial Services |
Lifecodes Corp.
Lifecodes Corp. Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Lifecodes Corp. is a company that provides paternity testing services. The company is based in Stamford, CT. Lifecodes was acquired by Orchid Cellmark, Inc., part of Laboratory Corp. of America Holdings from December 15, 2011 on December 06, 2001 for $26.53 million. The company was founded by Ronald C. Dorazio. | Commercial Services |
